神刊CA：30年乳腺癌死亡率下降43%，中美还有哪些差异？

参考文献：

[1]Xia,et al,2022:profiles,trends,and determinants.Chinese Medical Journal:March 5,2022-Volume 135-Issue 5-p 584-590

doi:10.1097/CM9.0000000000002108

[2]https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21754

[3]Miller KD,Nogueira L,Devasia T,Mariotto AB,Yabroff KR,Jemal A,Kramer J,Siegel RL.Cancer treatment and survivorship statistics,2022.CA Cancer J Clin.2022 Jun 23.doi:10.3322/caac.21731.Epub ahead of print.PMID:35736631.

[4]Zeng H,Chen W,Zheng R,Zhang S,Ji JS,Zou X,Xia C,Sun K,Yang Z,Li H,Wang N,Han R,Liu S,Li H,Mu H,He Y,Xu Y,Fu Z,Zhou Y,Jiang J,Yang Y,Chen J,Wei K,Fan D,Wang J,Fu F,Zhao D,Song G,Chen J,Jiang C,Zhou X,Gu X,Jin F,Li Q,Li Y,Wu T,Yan C,Dong J,Hua Z,Baade P,Bray F,Jemal A,Yu XQ,He J.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries.Lancet Glob Health.2018 May;6(5):e555-e567.doi:10.1016/S2214-109X(18)30127-X.PMID:29653628.

[5]Lei Fan,Kathrin Strasser-Weippl,Jun-Jie Li,Jessica St Louis,Dianne M Finkelstein,Ke-Da Yu,Wan-Qing Chen,Zhi-Ming Shao,Paul E Goss,Breast cancer in China,The Lancet Oncology,Volume 15,Issue 7,2014,Pages e279-e289,ISSN 1470-2045,https://doi.org/10.1016/S1470-2045(13)70567-9.

[6]GBD 2019 Cancer Risk Factors Collaborators.The global burden of cancer attributable to risk factors,2010-19:a systematic analysis for the Global Burden of Disease Study 2019.Lancet.2022 Aug 20;400(10352):563-591.doi:10.1016/S0140-6736(22)01438-6.PMID:35988567.

[7]Chen W,Xia C,Zheng R,Zhou M,Lin C,Zeng H,Zhang S,Wang L,Yang Z,Sun K,Li H,Brown MD,Islami F,Bray F,Jemal A,He J.Disparities by province,age,and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China:a comparative risk assessment.Lancet Glob Health.2019 Feb;7(2):e257-e269.doi:10.1016/S2214-109X(18)30488-1.PMID:30683243.

[8]中国研究型医院学会乳腺专业委员会中国女性乳腺癌筛查指南制定专家组.中国女性乳腺癌筛查指南(2022年版)[J].中国研究型医院,2022,09(2):6-13.